Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    23528626 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Efficacy and Safety of Asacol™ 4.8 g/Day (800 mg Tablets) for the Treatment of Active Ulcerative Colitis
Condition: Ulcerative Colitis
Intervention: Drug: Mesalamin
2 Completed Responsiveness of Endoscopic Evaluation in UC
Condition: Ulcerative Colitis
Intervention:

Study has passed its completion date and status has not been verified in more than two years.